HIV physician educational resources

Whether you have questions about universal screening, screening for specific therapies or monitoring treatment, you’ll find expert answers and advice here, across the entire HIV care continuum. The links below take you to articles and live presentations covering both primary and specialty care topics.

Medical Education Summaries
Sample Reports



Dr. Paul Sax


HIV Management – The Evolving Role of the Primary Care Physician

Recommendations for universal screening of patients aged 13–65 highlight the growing role for primary care physicians (PCPs) in HIV care. Dr. Paul Sax, Clinical Director, Division of Infectious Disease, Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School, reviews the role PCPs should play in HIV screening and diagnosis, and discusses the rationale for co-management of patients by PCPs and HIV infectious disease specialists. 

HIV Disease Management and the Role of Laboratory Testing


The Role of Laboratory Assays in the Management of HIV

John Baxter, MD, of Robert Wood Johnson Medical School and Cooper University Hospital in Camden, NJ, discusses the role of laboratory testing in the diagnosis and treatment of HIV infection. Topics include current guidelines for initiation of retroviral therapy, how HIV-1 drug resistance occurs and its clinical consequences, differences between genotypic and phenotypic drug resistance testing and the clinical utility of HIV-1 tropism assays.  

Dr. John Baxter


Current Issues and Hot Topics in HIV Treatment & Diagnostics

John Baxter, MD, Professor of Medicine, Division of Infectious Diseases, Robert Wood Johnson Medical School and Cooper University Hospital in Camden, NJ, summarizes updates to antiretroviral treatment guidelines featured in the U.S. Department of Health and Human Services’ (DHHS) revised “Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents,” 2011.  

Dr. Rick Pesano


HIV Tropism – Next Generation Genotypic Testing to Predict Virologic Response

Dr. Rick Pesano, Medical Director, Infectious Diseases, Quest Diagnostics Nichols Institute, reviews recent research, which indicates that genotypic tropism testing, with reflex to ultra-deep sequencing, may provide a valid alternative to phenotypic tests for determining viral tropism and subsequently predicting response to CCR5 co-receptor antagonist therapy. 

Dr. Jonathan Li


HIV Testing – Genotypic Technology in Tropism and Drug Resistance Testing

Dr. Jonathan Li, Infectious Disease Physician and Researcher, Brigham and Women’s Hospital, discusses how advances in genotypic testing technology offer physicians a new option for tropism screening and enable an accurate prediction of virologic response to therapy. 

Medical Education Summaries

HIV-1 Coreceptor Tropism, Proviral DNA test summary


Tropism Testing

Download a test summary PDF of our HIV-1 Co-Receptor Tropism, Proviral DNA test here. 

HIV-1 Coreceptor Tropism Reflex to Ultradeep Sequencing test summary

Tropism + Ultradeep Sequencing

Download a summary PDF of our HIV-1 Co-Receptor Tropism Reflex to Ultradeep Sequencing testing here. 

Sample Reports 

91431(X) HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexes
91691 HIV-1 Genotype (RTI, PI, Integrase Inhibitors)
90666 HIV-1 Co-Receptor Tropism with reflex to Ultradeep Sequencing
91299 HIV-1 Co_Receptor Tropism, Proviral DNA